Providing a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on Henry Schein HSIC in the last three months. The table below offers a condensed view of their ...

Securities updated their financial outlook on Henry Schein (NASDAQ:HSIC), increasing the price target to $78 from the previous $75, while maintaining a Neutral rating on the company's stock. According ...

Barrington analyst Michael Petusky raised the firm’s price target on Henry Schein (HSIC) to $90 from $82 and keeps an Outperform rating on the ...

Henry Schein (HSIC – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Allen Lutz from ...

Henry Schein Inc. closed 3.34% below its 52-week high of $82.63, which the company achieved on February 27th.

Henry Schein receives $250 million strategic investment from KKR, making them largest non-index fund shareholder.

Henry Schein, Inc. (NASDAQ:HSIC) shares are trading higher on Wednesday. The medical and dental supplies distributor ...

KKR is set to become the largest non-index fund shareholder in Henry Schein, acquiring a 12% stake through a $250 million investment.

Henry Schein has received a strategic investment of $250 million from KRR, giving the global investment firm a 12% stake in the company, with the option to purchase additional shares ...

Private equity firm KKR & Co. Inc. has invested $250 million in Henry Schein Inc., Long Island’s largest publicly traded ...

KKR & Co. has taken a 12% stake in Henry Schein Inc. and will work with the company to improve operations at the world’s ...